Difference between revisions of "Category:Graft versus host disease medications"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
m
m
 
(2 intermediate revisions by the same user not shown)
Line 1: Line 1:
Medications used to treat the symptoms of [[graft versus host disease (GVHD)]]. [[Ibrutinib (Imbruvica)]] is the only currently ''FDA-approved'' therapy for the treatment of chronic GVHD.
+
Medications used to treat the symptoms of [[graft versus host disease (GVHD)]].
 
 
[[Category:Transplant medications]]
 

Latest revision as of 22:58, 30 May 2019

Medications used to treat the symptoms of graft versus host disease (GVHD).

Subcategories

This category has only the following subcategory.